| Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers F Moisan, EB Francisco, A Brozovic, GE Duran, YC Wang, S Chaturvedi, ... Molecular oncology 8 (7), 1231-1239, 2014 | 124 | 2014 |
| Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to … GE Duran, YC Wang, F Moisan, EB Francisco, BI Sikic British journal of cancer 116 (10), 1318-1328, 2017 | 53 | 2017 |
| Relationships Between Genetic Polymorphisms and Anticancer Drug Cytotoxicity Vis-à-Vis the NCI-60 Panel V Le Morvan, R Bellott, F Moisan, S Mathoulin-Pélissier, J Bonnet, ... Pharmacogenomics 7 (6), 843-852, 2006 | 42 | 2006 |
| Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade F Moisan, S Oucherif, P Kaulanjan-Checkmodine, S Prey, B Rousseau, ... Proceedings of the national academy of sciences 118 (7), e2018690118, 2021 | 32 | 2021 |
| Mast cells as possible targets of propranolol therapy: an immunohistological study of beta-adrenergic receptors in infantile haemangiomas. S Prey, C Leaute‐Labreze, C Pain, F Moisan, P Vergnes, M Loot, A Taieb, ... Histopathology 65 (3), 2014 | 22 | 2014 |
| Identification of gene polymorphisms of human DNA topoisomerase I in the National Cancer Institute panel of human tumour cell lines F Moisan, M Longy, J Robert, V Le Morvan British journal of cancer 95 (7), 906-913, 2006 | 22 | 2006 |
| Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity F Moisan, A Laroche-Clary, C Auzanneau, N Ricard, P Pourquier, ... Carcinogenesis 33 (5), 962-968, 2012 | 19 | 2012 |
| UVB-induced DHODH upregulation, which is driven by STAT3, is a promising target for chemoprevention and combination therapy of photocarcinogenesis M Hosseini, L Dousset, P Michon, W Mahfouf, E Muzotte, V Bergeron, ... Oncogenesis 8 (10), 52, 2019 | 18 | 2019 |
| Loss of epidermal HIF-1α blocks UVB-induced tumorigenesis by affecting DNA repair capacity and oxidative stress W Mahfouf, M Hosseini, E Muzotte, M Serrano-Sanchez, L Dousset, ... Journal of Investigative Dermatology 139 (9), 2016-2028. e7, 2019 | 17 | 2019 |
| Decreased CCN3 in systemic sclerosis endothelial cells contributes to impaired angiogenesis P Henrot, F Moisan, P Laurent, P Manicki, P Kaulanjan-Checkmodine, ... Journal of Investigative Dermatology 140 (7), 1427-1434. e5, 2020 | 14 | 2020 |
| Is infantile hemangioma a neuroendocrine tumor? P Kaulanjan-Checkmodine, S Oucherif, S Prey, E Gontier, S Lacomme, ... International Journal of Molecular Sciences 23 (9), 5140, 2022 | 5 | 2022 |
| ERCC5 (XPG) status and clinical activity of trabectedin in patients with advanced soft-tissue sarcoma A Italiano, A Laurand, F Moisan, J Robert, I Ray-Coquard, JY Blay, B Bui, ... Cancer Research 70 (8_Supplement), 2699-2699, 2010 | 4 | 2010 |
| Effects of 5G-modulated 3.5 GHz radiofrequency field exposures on HSF1, RAS, ERK, and PML activation in live fibroblasts and keratinocytes cells A Joushomme, R Orlacchio, L Patrignoni, A Canovi, YL Chappe, ... Scientific Reports 13 (1), 8305, 2023 | 1 | 2023 |
| Is hyperpigmentation in Systemic Sclerosis a perivascular dermal tattoo? P Henrot, F Moisan, J Seneschal, A Taïeb, M Cario, ME Truchetet Journal of Investigative Dermatology 140 (11), 2308-2312. e2, 2020 | 1 | 2020 |
| Pericytes from Infantile Hemangioma regulate vessels formation in vitro P Kaulanjan-Checkmodine, F Moisan, S Prey, C Leaute-Labreze, M Loot, ... Journal of Investigative Dermatology 139 (9), S298-S298, 2019 | 1 | 2019 |
| Enhancement of paclitaxel and carboplatin therapy by CCL2 blockade in ovarian cancers F Moisan, EB Francisco, A Brozovic, GE Duran, YC Wang, S Seetharam, ... Cancer Research 72 (8_Supplement), 817-817, 2012 | 1 | 2012 |
| Energy metabolism rewiring following acute UVB irradiation is largely dependent on nuclear DNA damage P Michon, L Dousset, W Mahfouf, H Fatrouni, C Faucheux, E Muzotte, ... Journal of Investigative Dermatology 142 (12), S272-S272, 2022 | | 2022 |
| 470 Infantile hemangioma telocytes and noradrenaline are the prerequisite for response to propranolol S Oucherif, P Kaulanjan-Checkmodine, S Prey, M Loot, M Jullié, M Cario, ... Journal of Investigative Dermatology 142 (12), S261, 2022 | | 2022 |
| Rôle critique de l’aquaporine-1 et des télocytes dans la réponse de l’hémangiome infantile au propranolol F Moisan, S Ouchérif, P Kaulanjan-Checkmodine, S Prey, M Loot, ... Annales de Dermatologie et de Vénéréologie-FMC 1 (8), A125, 2021 | | 2021 |
| Metabolic Vulnerabilities as Predictive Biomarkers and Therapeutic Targets in Skin Carcinogenesis P MICHON, L DOUSSET, W MAHFOUF, E MUZOTTE, F MOISAN, ... Journal of Investigative Dermatology 141 (10), S192-S192, 2021 | | 2021 |
